This week we highlight AstraZeneca-Oxford COVID-19 vaccine challenges, FDA trends, drug-pricing reform hearings and more. … READ MORE >
5 things to know in life sciences: Week of March 15
This week we highlight possible heightened scrutiny related to pharma mergers, top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and more. … READ MORE >
An evolution of the economy: Living, and adapting, with COVID-19
What should middle market businesses consider in terms of a COVID-19 endemic future? Evaluating existing business models, updating policies and making investments in technology and digital infrastructure are just a few components. … READ MORE >
Understanding the rapid spread of COVID-19 variants
The emergence of COVID-19 variants is why the efficient and equitable distribution of vaccines across all nations is critical. … READ MORE >
5 things to know in life sciences: Week of March 8
This week we examine COVID-19 variants, heightened scrutiny on accelerated approval phase 4 confirmatory trials, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and more. … READ MORE >
5 things to know in life sciences: Week of March 1
In this week’s roundup we look at new data coming out of the U.K. and Israel on their COVID-19 vaccination programs’ results. We also highlight improvements in public perception of the pharmaceutical industry, a new executive order on supply chains and more. … READ MORE >
5 things to know in life sciences: Week of Feb. 22
In this week’s roundup we look at the latest news on Johnson & Johnson’s vaccine, a federal effort to expand genomic sequencing to track new COVID-19 variants, a major merger in the industry, and more.
… READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug to treat obesity, a new and less invasive treatment for sleep apnea, the impact of the pandemic on oncology trials and more. … READ MORE >
5 things to know in life sciences: Week of Feb. 8
Recent industry news includes the impact of new COVID-19 variants on existing vaccines for the disease, the outlook for drug pricing reforms under the Biden administration, and the promise of 3D-printed hearts. … READ MORE >
5 things to know in life sciences: Week of Feb. 1
This week, we look at mRNA drug manufacturing capacity, gene therapy investments, news of a new FDA role dedicated to medical device cybersecurity, and more. … READ MORE >